Heartseed Inc. and Novo Nordisk - in partnership since June 2021 - have announced that the first patient has been successfully dosed in a clinical study with HS-001, a cell therapy designed to ...

This advertisement has not loaded yet, but your article continues below. 'If you want people to adopt it, they need to have trust. If there's no adoption, we will squander the incredible potential ...